Method of analysis of some antitumor - Active alkaloids from Catharanthus roseus

Pharmaceutical Chemistry Journal

Volumn 30, Issue 6, 1996, Pages 391-399

  Volkov, S K ^a  

^a All Russia Science Research Institute of Medicinal and Aromatic Plants   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27544480067     PISSN: 0091150X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02219327     Document Type: Article

References (122)

1. N. Cartner and B. Ling, V mire nauki, No. 5, 14-22 (1989).
2. A. F. Gammerman, G. N. Kadaev, and A. A. Yatsenko-Khmelevskii, Medicinal Plants [in Russian], Moscow (1990).
3. Yu. A. Ovchinnikov, Bioorganic Chemistry [in Russian], Moscow (1987).
4. F. Garcia, Proc. Eight Pacific Sci. Congr. Pacific Sci. Assoc., 1953;
5. Nat. Res. Council Philippines, 4, 182-194 (1954).
6. R. L. Noble, C. T. Beer, and J. H. Cutts, Ann. N. Y. Acad. Sci., 76, 882-894 (1958).
7. T. Peckolt, Ber. Deutsch. Pharm. Ges., 20, 36-58 (1910).
8. I. S. Johnson, H. F. Wright, G. H. Svoboda, et al., Cancer Res., 20, 1016-1022 (1960).
9. I. S. Johnson, J. G. Armstrong, M. Gorman et al., Cancer Res., 23, 1390-1427 (1963).
10. G. Stix, V mire nauki, No. 2-3, 137-139 (1993).
11. Van Der Heijden, W. Snoeijer, and R. Verpoorte, Pharm. Weekbl., 127, 1283-1290 (1992).
12. G. H. Svoboda, N. Neuss, M. Gorman, J. Am. Pharm. Assoc. Sci. Ed., 48, 659-666 (1959).
13. N. J. Cone, R. Miller, and N. J. Neuss, Pharm. Sci., 52, 688-692 (1963).
14. N. R. Farnsworth, R. N. Blomster, D. Damratoski, et al., J. Nat. Prorf., 27, 302-314 (1964).
15. Vinblastine Sulphate. British Pharmacopoeia 1973, London Her Majesty's Stationery office (1973), p. 495.
16. Vinblastine Sulphate. British Pharmacopoeia 1980, Vol. 1, London Her Majesty's Stationery office, (1980), pp. 472-473.
17. Vinblastine Sulphate. British Pharmacopoeia 1988, Vol. 1, London Her Majesty's Stationery office (1988), pp. 594-595.
18. Vincristine Sulphate. British Pharmacopoeia 1973, London Her Majesty's Stationery office (1973), p. 496.
19. Vincristine Sulphate. British Pharmacopoeia 1980, Vol. 1, London Her Majesty's Stationery office (1980), p. 473.
20. Vincristine Sulphate. British Pharmacopoeia 1988, Vol. 1, London Her Majesty's Stationery office (1988), 595-596.
21. Rosevin. Vinblastine Sulfate. Temporal Pharmacopeial Standard, VFS 42-1096-81.
22. N. R. Farnsworth and I. M. Hilinski, J. Chromatogr., 18, 184-188 (1965).
23. Vinblastine Sulphate. British Pharmacopoeia 1993, Vol. 1, HMSO, London (1993), p. 701.
24. Vincristine Sulphate. British Pharmacopoeia 1993, Vol. 1, HMSO, London (1993), p. 702.
25. C. T. Beer, J. H. Cutts, R. L. Noble, Vincaleukoblastine., US Patent 3,097,137 (1963).
26. J. H. Burns, Analytical Profiles of Drug Substances K. Florey (ed.). Vol. 1, New York, London (1972), pp. 443-462.
27. J. H. Burns, Analytical Profiles of Drug Substances K. Florey (ed.). Vol. 1, New York, London (1972), pp. 463-480.
28. Vinblastine Sulfate The United States Pharmacopeia, XIX, United States Pharmacopeia Convention, Inc. Rockville, USA (1975), p. 535.
29. Vinblastine Sulfate. The United States Pharmacopeia, XX, United States Pharmacopeia Convention, Inc. Rockville, USA (1980), p. 843.
30. Vinblastine Sulfate. The United States Pharmacopeia, XXI, United States Pharmacopeia Convention, Inc. Rockville, USA (1985), pp. 1115-1116.
31. Vinblastine Sulfate. The United States Pharmacopeia, XXII, United States Pharmacopeia Convention, Inc. Rockville, USA (1990), pp. 1447-1448.
32. Vincristine Sulfate. The United States Pharmacopeia, XIX, United States Pharmacopeia Convention, Inc. Rockville, USA (1975), p. 536.
33. Vincristine Sulfate. The United States Pharmacopeia, XX, United States Pharmacopeia Convention, Inc. Rockville, USA (1980).
34. Vincristine Sulfate. The United States Pharmacopeia, XXI, United States Pharmacopeia Convention, Inc. Rockville, USA (1985), pp. 1116-1117.
35. Vincristine Sulfate. The United States Pharmacopeia, XXII, United States Pharmacopeia Convention, Inc. Rockville, USA (1990), p. 1449.
36. Vincristine Sulfate. International Pharmacopeia, 3rd Edition, Vol. 3, Geneve (1990), pp. 374-376.
37. G. H. Svoboda, I. S. Johnson, and M. Gorman, J. Pharm. Sci., 51, 707-720 (1962).
38. G. H. Svoboda, A. J. Barnes, Jr., et al., U. S. Patent 3,205,220 (1965).
39. N. Neuss, M. Gorman, G. H. Svoboda, et al, J. Am. Chem. Soc., 81, 4754-4755 (1959).
40. G. H. Svoboda, Lloydia, 42, 173-178 (1961).
41. T. Endo, A. Goodbody, and M. Misawa, Planta Med., 53, 479-482 (1987).
42. J. P. Kutney, T. Hibino, E. Jahngen, et al., Helv. Chim. Acta, 59, 2858-2882 (1976).
43. J. P. Kutney, T. Honda, P. M. Kazmater, et al., Helv. Chim. Acta, 63, 366-374 (1980).
44. J. Balsevich, L. R. Hogge, A. J. Berry, et al., J. Nat. Prod., 51, 1173-1177 (1988).
45. S. K. Volkov and E. I. Grodnitskaya, Khim.-Farm. Zh., 25(9), 77-78 (1991).
46. I. M. Jakovljevic, J. Pharm. Sci., 2, 187-188 (1962).
47. I. M. Jakovljevic, L. D. Seay, and R. W. Shaffer, J. Pharm. Sci., 53, 553-557 (1964).
48. Vinblastine Sulfate. The United States Pharmacopeia, XVIII, Mack Publishing Comp. Easton, USA (1970), p. 772.
49. Vincristine Sulfate. The United States Pharmacopeia, XVIII, Mack Publishing Comp. Easton, USA (1970), p. 773.
50. A. N. Massoud, N. R. Farnsworth, L. A. Sciuchetti, et al., J. Nat. Products, 31, 202-207 (1968).
51. P. Horvath and G. Ivanyi, Acta Pharm. Hung., 53, 150-157 (1982).
52. Leaves of Catharanthus roseus, Temporal Pharmacopeial Standard, VFS 42-1106-81.
53. L. A. Sapunova, A. V. Gaevskii, G. A. Maslova, et al., Khim.-Farm. Zh., 16, 708-715 (1982).
54. D. Drapeau, H. W. Blanch, and C. R. Wilke, J. Chromatogr., 390, 297-306 (1987).
55. S. Gorog, B. Herenyi, and K. Jovanovics, J. Chromatogr., 139, 203-206 (1977).
56. M. Verzele, L. De Taeye, J. Van Dyck, et al., J. Chromatogr., 214, 95-99 (1981).
57. J.-P. Renaudin, J. Chromatogr., 291, 165-174 (1984).
58. L. D. Apelgren, D. L. Zimmerman, S. L. Briggs, et al., Cancer Res., 50, 3540-3544 (1990).
59. J. R. F. Corvalan, W. Smith, and V. A. Gore, Int. J. Cancar., No. 2, Suppl., 22-25 (1988).
60. M. Summerhayes, J. Pharm, 249, 120-121 (1992).
61. N. M. Varki, R. A. Reisfeld, L. E. Walker, Monoclonal Antibodies and Cancer Therapy. Alan R. Liss, Inc., New York (1985), pp. 207-214.
62. J. H. Keller, W. D. Ensminger, Am. J. Hosp. Pharm., 39, 1321-1323 (1982).
63. K. N. Thimmaiah and V. S. Sethi, Cancer Res., 45, 5382-5385 (1985).
64. M. De Smet, S. J. P. Van Belle, G. A. Storme, et al., J. Chromatogr., 345, 309-321 (1985).
65. J. H. Beijnen, C. Neef and O. J. A. T. Meuwissen, Am. J. Hosp. Pharm., 43, 3022-3027 (1986).
66. M. De Smet, S. J. Van Belle, V. Seneca, et al., J. Chromatogr., 416, 375-381 (1987).
67. J. Black, D. D. Buechter, J. W. Chinn, et al., J. Pharm. Sci., 77, 630-634 (1988).
68. J. Black, D. D. Buechter, and D. E. Thurston, Drug Intell. Clin. Pharm., 22, 634-636 (1988).
69. D. E. M. M. Vendrig, B. P. G. M. Smeets, J. H. Beijnen, et al., Int. J. Pharm., 43, 131-138 (1988).
70. D. E. M. M. Vendrig, J. H. Beijnen, O. A. Van Der Houwen, et al., Int. J. Pharm., 50, 189-196 (1989).
71. R. Steffeck, A. Alam, and S. Pai, ASHP Midyear Clin. Meet., 26, 394R (1991).
72. T. Dine, M. Luyckx, J. C. Cazin, et al., Int. J. Pharm., 77, 279-285 (1991).
73. A. D. King, J. T. Stewart, F. W. Warren, et al., ASHP Midyear Clin. Meet., 28, 162E (1993).
74. S. K. Volkov and E. I. Grodnitskaya, Khim.-Farm. Zh., 29(8), 52-53 (1995).
75. D. E. M. M. Vendrig and J. J. M. Holthuis, Trends Anal. Chem., 8, 141-145 (1989).
76. J. A. Houghton, P. A. Torrance, and P. J. Houghton, Anal. Biochem., 134, 450-454 (1983).
77. D. E. M. M. Vendrig, J. J. M. Holthuis, V. Erdelyi-Toth, et al., J. Chromatogr., 414, 91-100 (1987).
78. D. E. M. M. Vendrig, J. Teeuwsen, J. J. M. Holthuis, et al., J. Chromatogr., 424, 83-94 (1988).
79. D. E. M. M. Vendrig, J. Teeuwsen, J. J. M. Holthuis, et al., J. Chromatogr., 434, 145-155 (1988).
80. O. Van Tellingen, J. H. Beijnen, R. Baurain, et al., J. Chromatogr., 553, 47-53 (1991).
81. M. Bloemhof, K. N. Van Dijk, and S. S. N. De Graaf, J. Chromatogr., 512, 171-179 (1991).
82. S. J. P. Van Belle, M. De Smet, W. De Neve, et al., J. Chromatogr., 578, 223-229 (1992).
83. D. Van Tellingen, J. H. Beijnen, and W. J. Nooijen, Cancer Chemother. Pharmacol., 32, 286-292 (1993).
84. D. Van Tellingen, J. H. Beijnen, and W. J. Nooijen, Cancer Res., 53, 2061-2065 (1993).
85. K. M. Pardasani, S. Singh, and J. P. S. Sarin, Indian J. Pharm. Sci., 41, 207-208 (1979).
86. J. G. D Marr, P. Horvath, H. P. Scott, et al., J. Pharm. Pharmacol., 37 (Suppl.), 12P (1985).
87. S. Mandal and M. L. Maheshwart, Indian J. Pharm. Sci., 49, 205-209 (1987).
88. S. Mandal, V. K. Srivastava, and M. L. Maheshwari, Indian J. Pharm. Sci, 43, 222-224 (1981).
89. S. K. Volkov and E. I. Grodnitskaya, Abstracts of Papers. The 5th All-Union Symp. on Molecular Liquid Chromatography [in Russian], Riga (1990).
90. S. K. Volkov and E. I. Grodnitskaya, Zh. Fiz. Khim., 65, 2860-2862 (1991).
91. S. K. Volkov and E. I. Grodnitskaya, Zh. Anal. Khim., 26(12), 2062-2066 (1992).
92. S. K. Volkov and E. I. Grodnitskaya, J. Chromatogr., 660, 405-408 (1994).
93. J. P. Kutney, B. Aweryn, L. S. L. Choi, et al., Tetrahedron., 39, 3781-3795 (1983).
94. Y. Miura, K. Hirata, N. Kurano, et al., Planta Med., 54, 18-20 (1988).
95. D. G. I. Kingston, J. Nat. Prod., 42, 237-260 (1979).
96. O. Van Tellingen, J. H. Beijnen, and W. J. Nooyen, J. Pharm Biomed. Anal., 9, 1077-1082 (1991).
97. T. Braun, A. Klein, and S. Zsindely, Trends Anal. Chem., 11, 5-7 (1992).
98. L. Fukal and J. Kas, Trends Anal. Chem., 8, 112-116 (1989).
99. S. K. Volkov, Medical Plant Growing: A Review of Information [in Russian], Moscow (1990), Issue 1, pp. 13-25.
100. S. K. Volkov, Usp. Khim., 62, 831-842 (1993).
101. C. J. Barnett, G. J. Cullinan, K. Gerzon, et al., J. Med. Chem., 21, 88-96 (1978).
102. M. A. Root, K. Gerzon, and R. W. Dyke, Fed. Anal. Chem. Spectr. Soc., 2nd Nat. Meet. Indianapolis, IN, USA (1975) p. 125, Abstr. 183.
103. R. J. Owellen, C. A. Hartike, and F. O. Hains, Cancer Res., 37 2597-2602 (1977).
104. R. J. Owellen, C. A. Hartike, and F. O. Hains, Cancer Res., 37, 2603-2607 (1977).
105. R. J. Owellen, M. Blair, A. Van Tosh, et al., Cancer Treat. Rep., 65, 469-475 (1981).
106. V. S. Sethi, S. S. Burton, and D. V. Jackson, Cancer Chemother. Pharmacol., 4, 183-187 (1980).
107. R. Rahmani, J. Barbet, and J. P. Cano, Clin. Chim. Acta, 129, 57-69 (1983).
108. M. P. Hacker, J. R. Dank, and W. B. Ershlar, Cancer Res., 44, 478-481 (1984).
109. M. C. Cibotti, C. Freier, J. Andrieux, et al., Phytochemistry, 29, 2109-2114 (1990).
110. P. A. Ponarotti, R. Rahmani, M. Martin, et al., Molec. Immunol., 22, 277-284 (1985).
111. J. D. Teale, J. M. Clough, and V. Marks, Br. J. Clin. Pharmacol., 4, 169-172 (1977).
112. A. S. Perlin, Oxidation. Techniques and Applications in Organic Synthesis, Vol. 1, Dekker, New York (1969), pp. 189-212.
113. J. J. Langone, M. R. D'Onofrio, and H. Van Vunakis, Anal. Biochem., 95, 214-221 (1979).
114. M. Lounasmaa, R. Jokela, A. Huhtikangas, et al., Heterocycles., 24, 1355-1360 (1986).
115. A. Huhtikangas, T. Lehtola, S. Lapinjoki, et al., Planta Med., 53, 85-87 (1987).
116. S. P. Lapinjoki, H. M. Verajankorva, A. E. Huhtikangas, et al., J. Immunoassay, 7, 113-128 (1986).
117. S. Lapinjoki, H. Verajankorva, J. Heiskanen, et al., Planta Med., 53, 565-567 (1987).
118. K. Hirata, M. Kobayashi, K. Miyamoto, et al., Planta Med., 55, 262-264 (1989).
119. S. K. Volkov, Author's Abstract of Candidate's Thesis [in Russian], Moscow (1992).
120. S. K. Volkov and A. I. Miroshnikov, Can. J. Physiol. Pharmacol., 72(1), 613, Abstr., P24.1.20 (1994).
121. S. K. Volkov and A. I. Miroshnikov, Khim.-Farm. Zh., 28(11), 43-45 (1994).
122. S. K. Volkov, Khim.-Farm. Zh., 29(8), 49-52 (1995).